HERE TO SERVE HOLDING CORPJun 16, 20211 min readHere to Serve Holding Corp. Acquires 15% Ownership in Kaiyon Biotech Inc...Here To Serve Holdings Corp. (OTC Pink: HTSC) (the "Company") is pleased to announce its wholly owned subsidiary, ICF Industries Inc., has purchased a 15% non-dilutive stake in Kaiyon Biotech Inc. ("Kaiyon"). Kaiyon is a company creating medicines using psilocybin to treat debilitating conditions.According to Cesar Herrera, President of ICF Industries, "Kaiyon doctors are early recipients of KFDA approval to study psilocybin in South Korea. We believe the scientists, doctors and researchers involved in Kaiyon are amongst the best in the world and they will be studying at Kaiyon's Bio-lab. We cannot be happier with this arrangement between the Company, Kaiyon, and Pervasip Corp. We believe we have amassed a world-class group of professionals for studying the positive effects of psilocybin."A royalty agreement is being negotiated by the team and will be announced shortly.
Here To Serve Holdings Corp. (OTC Pink: HTSC) (the "Company") is pleased to announce its wholly owned subsidiary, ICF Industries Inc., has purchased a 15% non-dilutive stake in Kaiyon Biotech Inc. ("Kaiyon"). Kaiyon is a company creating medicines using psilocybin to treat debilitating conditions.According to Cesar Herrera, President of ICF Industries, "Kaiyon doctors are early recipients of KFDA approval to study psilocybin in South Korea. We believe the scientists, doctors and researchers involved in Kaiyon are amongst the best in the world and they will be studying at Kaiyon's Bio-lab. We cannot be happier with this arrangement between the Company, Kaiyon, and Pervasip Corp. We believe we have amassed a world-class group of professionals for studying the positive effects of psilocybin."A royalty agreement is being negotiated by the team and will be announced shortly.